Blocking Macrophage Leukotriene B4 Prevents Endothelial Injury and Reverses Pulmonary Hypertension
暂无分享,去创建一个
L. Farkas | N. Voelkel | M. Inayathullah | J. Rajadas | M. Peters-Golden | M. Nicolls | M. Rabinovitch | Rasa Tamosiuniene | R. Zamanian | Xinguo Jiang | G. Dhillon | L. Gera | W. Tian | Y. Sung | J. Qian | Marina Fridlib | Jin Qian | Jayakumar Rajadas
[1] N. Zhong,et al. Sodium tanshinone IIA sulfonate inhibits canonical transient receptor potential expression in pulmonary arterial smooth muscle from pulmonary hypertensive rats. , 2013, American journal of respiratory cell and molecular biology.
[2] B. Dahal,et al. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.
[3] Qiwei Yang,et al. Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[4] C. Riccardi,et al. Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New , 2012, Clinical & developmental immunology.
[5] M. Humbert,et al. Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension , 2012, European Respiratory Journal.
[6] C. Mohan,et al. Macrophage subpopulations in systemic lupus erythematosus. , 2012, Discovery medicine.
[7] M. Humbert,et al. Inflammation in pulmonary arterial hypertension , 2003, European Respiratory Journal.
[8] M. Humbert,et al. The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension , 2013, Clinical Reviews in Allergy & Immunology.
[9] C. Long,et al. Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary Hypertension , 2011, Circulation research.
[10] Howard Y. Chang,et al. Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. , 2011, The Journal of clinical investigation.
[11] H. Ghofrani,et al. Mechanisms of disease: pulmonary arterial hypertension , 2011, Nature Reviews Cardiology.
[12] O. Liang,et al. Early Macrophage Recruitment and Alternative Activation Are Critical for the Later Development of Hypoxia-Induced Pulmonary Hypertension , 2011, Circulation.
[13] S. Archer,et al. A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. , 2011, American journal of respiratory and critical care medicine.
[14] Cord Sunderkötter,et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.
[15] E. Ashley,et al. BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways , 2011, The Journal of cell biology.
[16] H. Mitsuya,et al. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis , 2010, Arthritis research & therapy.
[17] B. Samuelsson,et al. Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis. , 2010, Biochemical and biophysical research communications.
[18] L. Karlsson,et al. Leukotriene A(4) hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness. , 2010, American journal of respiratory and critical care medicine.
[19] M. Peters-Golden,et al. Intrapulmonary Administration of Leukotriene B4 Enhances Pulmonary Host Defense against Pneumococcal Pneumonia , 2010, Infection and Immunity.
[20] M. Maitland,et al. Inflammation, growth factors, and pulmonary vascular remodeling. , 2009, Journal of the American College of Cardiology.
[21] Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ Expression , 2009, PloS one.
[22] J. Haeggström,et al. Leukotriene B4‐ induced changes in vascular permeability are mediated by neutrophil release of heparin‐binding protein (HBP/CAP37/azurocidin) , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] Xianlu Zeng,et al. Leukotriene B4 regulates proliferation and differentiation of cultured rat myoblasts via the BLT1 pathway , 2009, Molecules and cells.
[24] L. Badimón,et al. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin , 2009, Thrombosis and Haemostasis.
[25] J. Smolen,et al. Phenotypic and Functional Analysis of CD4+CD25−Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus1 , 2009, The Journal of Immunology.
[26] N. Flamand,et al. Phosphorylation of Serine 271 on 5-Lipoxygenase and Its Role in Nuclear Export* , 2009, Journal of Biological Chemistry.
[27] S. Dudek,et al. Regulation of vascular permeability by sphingosine 1-phosphate. , 2009, Microvascular research.
[28] N. Voelkel,et al. The cancer paradigm of severe pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.
[29] W. Henderson,et al. Mechanisms of disease: Leukotrienes , 2007 .
[30] I. McMurtry,et al. Rodent models of PAH: are we there yet? , 2007, American journal of physiology. Lung cellular and molecular physiology.
[31] N. Voelkel,et al. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling. , 2007, American journal of respiratory and critical care medicine.
[32] Anders Gabrielsen,et al. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[33] D. Badesch,et al. Autoimmunity and pulmonary hypertension: a perspective , 2005, European Respiratory Journal.
[34] G. Hansson,et al. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Spiegel,et al. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling , 2005, Journal of Cell Science.
[36] Jesse D. Roberts,et al. Inhibition of Atherogenesis in BLT1-Deficient Mice Reveals a Role for LTB4 and BLT1 in Smooth Muscle Cell Recruitment , 2005, Circulation.
[37] J. Loscalzo,et al. Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice , 2005, Circulation.
[38] P. Jones,et al. Epidermal Growth Factor Receptor Blockade Mediates Smooth Muscle Cell Apoptosis and Improves Survival in Rats With Pulmonary Hypertension , 2005, Circulation.
[39] S. Archer,et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. , 2005, The Journal of clinical investigation.
[40] K. Miyazono,et al. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[41] J. Dyck,et al. Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis , 2004, Circulation research.
[42] P. Libby,et al. Hypochlorous Acid, a Macrophage Product, Induces Endothelial Apoptosis and Tissue Factor Expression: Involvement of Myeloperoxidase-Mediated Oxidant in Plaque Erosion and Thrombogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[43] S. Wang,et al. Leukotriene A4 hydrolase as a target for cancer prevention and therapy. , 2004, Current cancer drug targets.
[44] L. Jacobsson,et al. CD4+ T-lymphocytopenia--a frequent finding in anti-SSA antibody seropositive patients with primary Sjögren's syndrome. , 2004, The Journal of rheumatology.
[45] N. Voelkel,et al. Oxidative stress in severe pulmonary hypertension. , 2004, American journal of respiratory and critical care medicine.
[46] K. Ota,et al. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults , 1986, Cancer Immunology, Immunotherapy.
[47] P. Hedqvist,et al. Increase in vascular permeability induced by leukotriene b4 and the role of polymorphonuclear leukocytes , 1982, Inflammation.
[48] M. Peters-Golden,et al. Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Peters-Golden,et al. 5-lipoxygenase and FLAP. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.
[50] H. Kato,et al. Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma. , 2003, Journal of the National Cancer Institute.
[51] Eugene Y. Kim,et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4 , 2002, Nature Medicine.
[52] O. Werz,et al. Arachidonic Acid Promotes Phosphorylation of 5-Lipoxygenase at Ser-271 by MAPK-activated Protein Kinase 2 (MK2)* , 2002, The Journal of Biological Chemistry.
[53] J. Dyck,et al. Dichloroacetate, a Metabolic Modulator, Prevents and Reverses Chronic Hypoxic Pulmonary Hypertension in Rats: Role of Increased Expression and Activity of Voltage-Gated Potassium Channels , 2002, Circulation.
[54] V. Botbol,et al. Bestatin as an experimental tool in mammals. , 2001, Current drug metabolism.
[55] P. Hirth,et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] O. Werz,et al. 5-lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[57] H. Ohira,et al. Athymic Nude Rats Develop Severe Pulmonary Hypertension following Monocrotaline Administration , 2000, International Archives of Allergy and Immunology.
[58] A. Newby,et al. Nitric oxide and the proliferation of vascular smooth muscle cells. , 1999, Cardiovascular research.
[59] R. Busse,et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.
[60] F. Abe,et al. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines , 1999, Leukemia.
[61] Vincent Bours,et al. Reactive Oxygen Intermediate-Dependent NF-κB Activation by Interleukin-1β Requires 5-Lipoxygenase or NADPH Oxidase Activity , 1999, Molecular and Cellular Biology.
[62] M. Peters-Golden,et al. Regulation of 5-lipoxygenase metabolism in mononuclear phagocytes by CD4 T lymphocytes. , 1999, Experimental lung research.
[63] N. Voelkel,et al. Pulmonary hypertension and inflammation. , 1998, The Journal of laboratory and clinical medicine.
[64] K. Shroyer,et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. , 1998, The Journal of clinical investigation.
[65] N. Voelkel,et al. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension. , 1998, American journal of respiratory and critical care medicine.
[66] J. Zweier,et al. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[67] T. Tanita,et al. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension]. , 1997, Nihon Kyobu Shikkan Gakkai zasshi.
[68] L. Kobzik,et al. Characterization of murine lung interstitial macrophages in comparison with alveolar macrophages in vitro. , 1996, Journal of immunology.
[69] B. Koller,et al. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. , 1996, The Journal of clinical investigation.
[70] B. Autran,et al. T lymphocyte subsets in primary antiphospholipid syndrome. , 1994, The Journal of rheumatology.
[71] N. Voelkel,et al. Modulation of pulmonary leukotriene formation and perfusion pressure by bestatin, an inhibitor of leukotriene A4 hydrolase. , 1994, Biochemical pharmacology.
[72] N. Dallaire,et al. Metabolic disposition of leukotriene B4 (LTB4) and oxidation‐resistant analogues of LTB4 in conscious rabbits , 1994, British journal of pharmacology.
[73] J. Bishop,et al. Macrophages are required for cell death and tissue remodeling in the developing mouse eye , 1993, Cell.
[74] G. Kane. Primary pulmonary hypertension in HIV infection. , 1992, Chest.
[75] N. Mahy,et al. Peripheral blood T-lymphocyte subsets in autoimmune thyroid disease. , 1992, Journal of investigational allergology & clinical immunology.
[76] F. Fitzpatrick,et al. Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes. , 1991, The Journal of biological chemistry.
[77] C. Shelly,et al. Alterations in the pattern of arachidonate metabolism accompany rat macrophage differentiation in the lung. , 1990, Journal of immunology.
[78] M. Peters-Golden,et al. Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects. , 1988, The American review of respiratory disease.
[79] B. Lehnert,et al. Pulmonary Interstitial Macrophages: Isolation and Flow Cytometric Comparisons With Alveolar Macrophages and Blood Monocytes , 1988, Journal of leukocyte biology.
[80] P. Cannon,et al. Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. , 1986, The Journal of biological chemistry.
[81] P. Holt,et al. Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. , 1985, Immunology.
[82] N. Voelkel,et al. Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. , 1983, The New England journal of medicine.
[83] M. Peck,et al. The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. , 1981, Prostaglandins.